Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Venous Thrombosis

Free Subscription Articles published in Am J Hematol Retrieve available abstracts of 15 articles: HTML format

Single Articles

July 2022
1. XIAOHUA L, Liu Y, Qu C, Mol B, et al
   The association of iron deficiency anemia, thrombocytosis at delivery and postpartum venous thromboembolism.
   Am J Hematol. 2022 Jul 9. doi: 10.1002/ajh.26657.
   PubMed    
   
   
   May 2022
2. DA COSTA WL JR, Guffey D, Oluyomi A, Bandyo R, et al
   Patterns of venous thromboembolism risk, treatment, and outcomes among patients with cancer from uninsured and vulnerable populations.
   Am J Hematol. 2022 May 31. doi: 10.1002/ajh.26623.
   PubMed     Abstract available
   
   
   March 2022
3. BERG S, Kim SH, Wozniak A, Odetola O, et al
   COVID-19 Thromboembolism Incidence, Risk Factors and Anticoagulation Practices from a Chicago Metropolitan US Population.
   Am J Hematol. 2022 Mar 18. doi: 10.1002/ajh.26541.
   PubMed    
   
   
   
4. LI A, Martens KL, Nguyen D, Basom R, et al
   External Validation of the HIGH-2-LOW Model: A Predictive Score for Venous Thromboembolism after Allogeneic Transplant.
   Am J Hematol. 2022 Mar 9. doi: 10.1002/ajh.26521.
   PubMed     Abstract available
   
   
   November 2021
5. GERBER GF, DeZern AE, Chaturvedi S, Brodsky RA, et al
   A 15-year, single institution experience of anticoagulation management in paroxysmal nocturnal hemoglobinuria patients on terminal complement inhibition with history of thromboembolism.
   Am J Hematol. 2021 Nov 20. doi: 10.1002/ajh.26414.
   PubMed    
   
   
   October 2021
6. FENYVES BG, Mehta A, Kays KR, Beakes C, et al
   Plasma P-selectin is an early marker of thromboembolism in COVID-19.
   Am J Hematol. 2021 Oct 8. doi: 10.1002/ajh.26372.
   PubMed    
   
   
   June 2021
7. ABOU-ISMAIL MY, Moser KA, Smock KJ, Lim MY, et al
   Vaccine-induced thrombotic thrombocytopenia following Ad26.COV2.S vaccine in a man presenting as acute venous thromboembolism.
   Am J Hematol. 2021 Jun 7. doi: 10.1002/ajh.26265.
   PubMed    
   
   
   
8. TEFFERI A, Szuber N, Pardanani A, Hanson CA, et al
   Extreme thrombocytosis in low-risk essential thrombocythemia: Retrospective review of vascular events and treatment strategies.
   Am J Hematol. 2021;96:E182-E184.
   PubMed    
   
   
   May 2021
9. KRECAK I, Gardijan B, Brkicic J, Grubisic-Cabo R, et al
   Cryptic brain abscess - do not forget hereditary hemorrhagic teleangiectasia!
   Am J Hematol. 2021;96:640-642.
   PubMed    
   
   
   April 2021
10. ARCHULETA J, van der Graaf M, Kaptein FHJ, Althaus L, et al
    Sudden death due to massive bone marrow sequestration crisis in a patient with sickle cell disease.
    Am J Hematol. 2021;96:E100-E102.
    PubMed    
    
    
    March 2021
11. WARKENTIN TE, Smythe MA, Ali MA, Aslam N, et al
    Serotonin-release assay-positive but platelet factor 4-dependent enzyme-immunoassay negative: HIT or not HIT?
    Am J Hematol. 2021;96:320-329.
    PubMed     Abstract available
    
    
    December 2020
12. HANFF TC, Mohareb AM, Giri J, Cohen JB, et al
    Thrombosis in COVID-19.
    Am J Hematol. 2020;95:1578-1589.
    PubMed     Abstract available
    
    
    August 2020
13. STEFELY JA, Christensen BB, Gogakos T, Cone Sullivan JK, et al
    Marked factor V activity elevation in severe COVID-19 is associated with venous thromboembolism.
    Am J Hematol. 2020 Aug 24. doi: 10.1002/ajh.25979.
    PubMed     Abstract available
    
    
    July 2020
14. GUPTA VK, Strykowski R, Scarpato B, Lawrence R, et al
    The Effect of Anticoagulant Choice on Venous Thromboembolism Recurrence and Bleeding in Sickle Cell Disease.
    Am J Hematol. 2020 Jul 3. doi: 10.1002/ajh.25923.
    PubMed    
    
    
    October 2019
15. CHALAYER E, Teste A, Guyotat D, Elalamy I, et al
    Predicting the risk of venous thromboembolism in newly diagnosed myeloma with immunomodulatory drugs: external validation of the IMPEDE VTE score.
    Am J Hematol. 2019 Oct 15. doi: 10.1002/ajh.25658.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Venous Thrombosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: